Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

Cited In for PubMed (Select 19414607)

1.

The desmosomal protein desmoglein 1 aids recovery of epidermal differentiation after acute UV light exposure.

Johnson JL, Koetsier JL, Sirico A, Agidi AT, Antonini D, Missero C, Green KJ.

J Invest Dermatol. 2014 Aug;134(8):2154-62. doi: 10.1038/jid.2014.124. Epub 2014 Mar 4.

2.

Synchronous BRAF(V600E) and MEK inhibition leads to superior control of murine melanoma by limiting MEK inhibitor induced skin toxicity.

Gadiot J, Hooijkaas AI, Deken MA, Blank CU.

Onco Targets Ther. 2013 Nov 28;6:1649-58. doi: 10.2147/OTT.S52552. eCollection 2013.

3.

A double-edged sword: how oncogenes and tumor suppressor genes can contribute to chromosomal instability.

Orr B, Compton DA.

Front Oncol. 2013 Jun 27;3:164. doi: 10.3389/fonc.2013.00164. Print 2013.

4.

Anticancer effect of Tamarix gallica extracts on human colon cancer cells involves Erk1/2 and p38 action on G2/M cell cycle arrest.

Boulaaba M, Tsolmon S, Ksouri R, Han J, Kawada K, Smaoui A, Abdelly C, Isoda H.

Cytotechnology. 2013 Dec;65(6):927-36. doi: 10.1007/s10616-013-9564-4. Epub 2013 Jun 26.

5.

p21-activated kinase 1 (PAK1) can promote ERK activation in a kinase-independent manner.

Wang Z, Fu M, Wang L, Liu J, Li Y, Brakebusch C, Mei Q.

J Biol Chem. 2013 Jul 5;288(27):20093-9. doi: 10.1074/jbc.M112.426023. Epub 2013 May 7.

6.

Inhibition of vascular smooth muscle cell proliferation by Gentiana lutea root extracts.

Kesavan R, Potunuru UR, Nastasijević B, T A, Joksić G, Dixit M.

PLoS One. 2013 Apr 18;8(4):e61393. doi: 10.1371/journal.pone.0061393. Print 2013.

7.

IQGAP1 scaffold-kinase interaction blockade selectively targets RAS-MAP kinase-driven tumors.

Jameson KL, Mazur PK, Zehnder AM, Zhang J, Zarnegar B, Sage J, Khavari PA.

Nat Med. 2013 May;19(5):626-30. doi: 10.1038/nm.3165. Epub 2013 Apr 21.

8.

CInQ-03, a novel allosteric MEK inhibitor, suppresses cancer growth in vitro and in vivo.

Kim DJ, Lee MH, Reddy K, Li Y, Lim do Y, Xie H, Lee SY, Yeom YI, Bode AM, Dong Z.

Carcinogenesis. 2013 May;34(5):1134-43. doi: 10.1093/carcin/bgt015. Epub 2013 Jan 25.

9.

ΔNp63α regulates Erk signaling via MKP3 to inhibit cancer metastasis.

Bergholz J, Zhang Y, Wu J, Meng L, Walsh EM, Rai A, Sherman MY, Xiao ZX.

Oncogene. 2014 Jan 9;33(2):212-24. doi: 10.1038/onc.2012.564. Epub 2012 Dec 17.

10.

Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk.

Staser K, Park SJ, Rhodes SD, Zeng Y, He YZ, Shew MA, Gehlhausen JR, Cerabona D, Menon K, Chen S, Sun Z, Yuan J, Ingram DA, Nalepa G, Yang FC, Clapp DW.

J Clin Invest. 2013 Jan;123(1):329-34. doi: 10.1172/JCI66167. Epub 2012 Dec 10.

11.

Digitoxin and its analogs as novel cancer therapeutics.

Elbaz HA, Stueckle TA, Tse W, Rojanasakul Y, Dinu CZ.

Exp Hematol Oncol. 2012 Apr 5;1(1):4. doi: 10.1186/2162-3619-1-4.

12.

Extracellular signal-regulated kinase 2 (ERK2) mediates phosphorylation and inactivation of nuclear interaction partner of anaplastic lymphoma kinase (NIPA) at G2/M.

Illert AL, Zech M, Moll C, Albers C, Kreutmair S, Peschel C, Bassermann F, Duyster J.

J Biol Chem. 2012 Nov 2;287(45):37997-8005. doi: 10.1074/jbc.M112.373464. Epub 2012 Sep 6.

13.

Overexpression of a novel osteopetrosis-related gene CCDC154 suppresses cell proliferation by inducing G2/M arrest.

Liao W, Zhao R, Lu L, Zhang R, Zou J, Xu T, Wu C, Tang J, Deng Y, Lu X.

Cell Cycle. 2012 Sep 1;11(17):3270-9. doi: 10.4161/cc.21642. Epub 2012 Aug 16.

14.

Akt- and Erk-mediated regulation of proliferation and differentiation during PDGFRβ-induced MSC self-renewal.

Gharibi B, Ghuman MS, Hughes FJ.

J Cell Mol Med. 2012 Nov;16(11):2789-801. doi: 10.1111/j.1582-4934.2012.01602.x.

15.

Development and homeostasis of the skin epidermis.

Sotiropoulou PA, Blanpain C.

Cold Spring Harb Perspect Biol. 2012 Jul 1;4(7):a008383. doi: 10.1101/cshperspect.a008383.

16.

Norathyriol suppresses skin cancers induced by solar ultraviolet radiation by targeting ERK kinases.

Li J, Malakhova M, Mottamal M, Reddy K, Kurinov I, Carper A, Langfald A, Oi N, Kim MO, Zhu F, Sosa CP, Zhou K, Bode AM, Dong Z.

Cancer Res. 2012 Jan 1;72(1):260-70. doi: 10.1158/0008-5472.CAN-11-2596. Epub 2011 Nov 14.

17.

Mechanisms of aneuploidy induction by RAS and RAF oncogenes.

Kamata T, Pritchard C.

Am J Cancer Res. 2011;1(7):955-71. Epub 2011 Mar 29.

18.

A novel mechanism for ERK-dependent regulation of IL4 transcription during human Th2-cell differentiation.

Tripathi P, Sahoo N, Ullah U, Kallionpää H, Suneja A, Lahesmaa R, Rao KV.

Immunol Cell Biol. 2012 Aug;90(7):676-87. doi: 10.1038/icb.2011.87. Epub 2011 Oct 11.

19.

Growth inhibition of human hepatocellular carcinoma cells by overexpression of G-protein-coupled receptor kinase 2.

Wei Z, Hurtt R, Ciccarelli M, Koch WJ, Doria C.

J Cell Physiol. 2012 Jun;227(6):2371-7. doi: 10.1002/jcp.22972.

20.

Ras and Raf pathways in epidermis development and carcinogenesis.

Kern F, Niault T, Baccarini M.

Br J Cancer. 2011 Jan 18;104(2):229-34. doi: 10.1038/sj.bjc.6606009. Epub 2010 Nov 16. Review. Erratum in: Br J Cancer. 2011 Mar 29;104(7):1240.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk